Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Toku Sakashita"'
Autor:
Kaname Seki, Yosuke Mizuno, Toku Sakashita, Shintaro Nakano, Jun Tanno, Yasushi Okazaki, Toshihiro Muramatsu, Shigeyuki Nishimura, Takaaki Senbonmatsu
Publikováno v:
Journal of Pharmacological Sciences, Vol 133, Iss 3, Pp 156-161 (2017)
Activated factor X (FXa) plays an important role in thrombin generation and inflammation. Factor X is not converted constitutively to FXa, but only after intrinsic clotting factors are activated and/or cellular injury occurs. Although rivaroxaban is
Externí odkaz:
https://doaj.org/article/daf509b4b32b49f89c283988f0f48735
Autor:
Takaaki Senbonmatsu, Shintaro Nakano, Jun Tanno, Kaname Seki, Toshihiro Muramatsu, Yosuke Mizuno, Toku Sakashita, Shigeyuki Nishimura, Yasushi Okazaki
Publikováno v:
Journal of Pharmacological Sciences, Vol 133, Iss 3, Pp 156-161 (2017)
Activated factor X (FXa) plays an important role in thrombin generation and inflammation. Factor X is not converted constitutively to FXa, but only after intrinsic clotting factors are activated and/or cellular injury occurs. Although rivaroxaban is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0065147447762e411078a666d864871a
https://pubmed.ncbi.nlm.nih.gov/28314697
https://pubmed.ncbi.nlm.nih.gov/28314697
Autor:
Jun Tanno, Takaaki Senbonmatsu, Toku Sakashita, Toshihiro Muramatsu, Shigeyuki Nishimura, Shintaro Nakano, Kaname Seki, Yosuke Mizuno
Publikováno v:
Circulation Research. 119
Aim: Activated factor X (FXa) plays important roles in the thrombin generation and in inflammation, which is evoked during the endothelial damage. Although rivaroxaban is a selective FXa antagonist, it is one of the key therapies in ischemic heart di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b637a3cc39b9c6093f4937a98a83946d
https://doi.org/10.1161/res.119.suppl_1.315
https://doi.org/10.1161/res.119.suppl_1.315